Pittsburgh, PA, United States of America

Cognition Therapeutics, Inc.


USPTO Granted Patents = 14

% Expired Patents = 7.1


Forward Citations = 63

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Gilbert M Rishton (13 out of 17 patents)

silverMedal Susan M Catalano (12 out of 12 patents)

bronzeMedal Gary Charles Look (7 out of 14 patents)

4.  Hiromi Arai (1 out of 1 patent)

5.  Zoya Kai (1 out of 1 patent)

6.  Cody Lee Fullenwider (1 out of 1 patent)

7.  Kristin Beierle (1 out of 1 patent)

8.  Steven A Weissman (1 out of 1 patent)

9.  Mary Hamby (3 patents)

10.  Anthony Caggiano (1 patent)

11.  Nicholas Izzo (0 patent)


14 patents:

Company Overview
Cognition Therapeutics, Inc. is a biotechnology company based in Pittsburgh, PA, focused on developing innovative therapies for neurodegenerative diseases. The company specializes in the discovery and advancement of small molecule drugs aimed at addressing the underlying mechanisms of conditions such as Alzheimer's disease. By leveraging its proprietary technology platforms, Cognition Therapeutics is committed to improving the lives of patients through targeted treatment approaches that enhance cognitive function and overall brain health.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Cognition Therapeutics, Inc. USPTO Patent Assignee Logo
14 Patents

#144 in Pittsburgh, PA

#803 in Pennsylvania

#22,319 in US

#42,249 in the World

Pittsburgh, PA (US)
Pittsburgh, PA, United States of America
Forward Citations = 63

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cognition Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cognition-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…